Vascular Discovery 2026 Scientific Sessions  /  13. Concurrent Session 4a: Lipid Metabolism and Novel Therapeutic Targets in Atherosclerosis  /  Rethinking Lp(a) Metabolism: Do Extracellular Vesicles Shape Its Fate?
Logo

American Heart Association

  49
  0

Final ID:

Rethinking Lp(a) Metabolism: Do Extracellular Vesicles Shape Its Fate?

  • Reyes-soffer, Gissette  ( Columbia University Medical Center , New York , New York , United States )
    • Author Disclosures:
    Gissette Reyes-Soffer: DO have relevant financial relationships ; Consultant:Eli Lilly, Inc:Active (exists now) ; Consultant:Argenex:Active (exists now) ; Advisor:Novartis :Past (completed) ; Research Funding (PI or named investigator):Kaneka, Inc:Active (exists now) ; Consultant:Merck, Inc:Active (exists now)
Meeting Info:

Vascular Discovery 2026 Scientific Sessions

2026

Bellevue, Washington

Session Info:

13. Concurrent Session 4a: Lipid Metabolism and Novel Therapeutic Targets in Atherosclerosis

Friday, 05/15/2026 , 03:30PM - 05:00PM

Oral

More abstracts on this topic:
PIP2 metabolism as a novel therapeutic target for reverse cholesterol transport and atherosclerosis.

Gulshan Kailash, Khan Mariam

Lipoprotein(a) undergoes Endothelial Transcytosis via Activin receptor-Like Kinase 1: An Unexpected Mechanism for Residual Cardiovascular Risk

Henry Andria, Wang Ruoqi, Liu Yitong, Yee Ho Man Ryan, Fidora Sarah, Boffa Michael, Koschinsky Marlys, Wang Changsen, Lee Warren

More abstracts from these authors:
Implementing Ancestry-Aware Genetics in the Clinic: The Example of LPA

Reyes-soffer Gissette, Byambaa Enkhmaa, Berglund Lars

Lp(a) - A prevalent risk factor for cardiovascular disease

Reyes-soffer Gissette

You have to be authorized to contact abstract author. Please, Login
Not Available